1. Home
  2. OPTT vs CVKD Comparison

OPTT vs CVKD Comparison

Compare OPTT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTT
  • CVKD
  • Stock Information
  • Founded
  • OPTT 1984
  • CVKD 2022
  • Country
  • OPTT United States
  • CVKD United States
  • Employees
  • OPTT N/A
  • CVKD N/A
  • Industry
  • OPTT Electric Utilities: Central
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • OPTT Utilities
  • CVKD Health Care
  • Exchange
  • OPTT Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • OPTT 8.8M
  • CVKD 8.2M
  • IPO Year
  • OPTT 2007
  • CVKD 2023
  • Fundamental
  • Price
  • OPTT $0.36
  • CVKD $0.43
  • Analyst Decision
  • OPTT
  • CVKD Strong Buy
  • Analyst Count
  • OPTT 0
  • CVKD 2
  • Target Price
  • OPTT N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • OPTT 85.8M
  • CVKD 71.6K
  • Earning Date
  • OPTT 09-11-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • OPTT N/A
  • CVKD N/A
  • EPS Growth
  • OPTT N/A
  • CVKD N/A
  • EPS
  • OPTT N/A
  • CVKD N/A
  • Revenue
  • OPTT $4,933,000.00
  • CVKD N/A
  • Revenue This Year
  • OPTT N/A
  • CVKD N/A
  • Revenue Next Year
  • OPTT N/A
  • CVKD N/A
  • P/E Ratio
  • OPTT N/A
  • CVKD N/A
  • Revenue Growth
  • OPTT 96.77
  • CVKD N/A
  • 52 Week Low
  • OPTT $0.12
  • CVKD $0.36
  • 52 Week High
  • OPTT $0.68
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • OPTT 57.45
  • CVKD 40.00
  • Support Level
  • OPTT $0.37
  • CVKD $0.43
  • Resistance Level
  • OPTT $0.42
  • CVKD $0.49
  • Average True Range (ATR)
  • OPTT 0.08
  • CVKD 0.02
  • MACD
  • OPTT -0.00
  • CVKD -0.00
  • Stochastic Oscillator
  • OPTT 43.61
  • CVKD 0.17

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: